<SEC-DOCUMENT>0001193125-22-256260.txt : 20221003
<SEC-HEADER>0001193125-22-256260.hdr.sgml : 20221003
<ACCEPTANCE-DATETIME>20221003091801
ACCESSION NUMBER:		0001193125-22-256260
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221003
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221003
DATE AS OF CHANGE:		20221003

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		221286225

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d403551d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20221003" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2022-10-03_to_2022-10-03">LIGAND PHARMACEUTICALS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-10-03_to_2022-10-03">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-10-03_to_2022-10-03">0000886163</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="lgnd-20221003.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-10-03_to_2022-10-03"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-10-03</xbrli:startDate> <xbrli:endDate>2022-10-03</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-10-03_to_2022-10-03">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt:datemonthdayyearen">October&#160;3, 2022</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">LIGAND PHARMACEUTICALS INCORPORATED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-10-03_to_2022-10-03">001-33093</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-10-03_to_2022-10-03">77-0160744</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer<br /></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-10-03_to_2022-10-03">3911 Sorrento Valley Boulevard</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-10-03_to_2022-10-03">Suite 110</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-10-03_to_2022-10-03">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-10-03_to_2022-10-03">CA</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-10-03_to_2022-10-03">92121</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-10-03_to_2022-10-03">(858)</ix:nonNumeric>&#160;<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-10-03_to_2022-10-03">550-7500</ix:nonNumeric></span></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report.)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-10-03_to_2022-10-03">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-10-03_to_2022-10-03">LGND</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-10-03_to_2022-10-03" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;3, 2022, Ligand Pharmaceuticals Incorporated (&#8220;Ligand&#8221;) issued a press release announcing that its board of directors set October&#160;26, 2022 as the record date for the dividend of shares of common stock of OmniAb, Inc. to be distributed to Ligand shareholders in order to effect the separation of Ligand and OmniAb into two independent, publicly traded companies, in connection with the previously announced business combination between OmniAb and Avista Public Acquisition Corp. II (&#8220;APAC&#8221;) (NASDAQ: AHPA). A copy of the press release, including additional details regarding the distribution, is filed as Exhibit 99.1 hereto and is incorporated herein in its entirety by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d403551dex991.htm">Press release dated October&#160;3, 2022 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">LIGAND PHARMACEUTICALS INCORPORATED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: October&#160;3, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Charles S. Berkman</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Charles S. Berkman</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President, General Counsel and Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d403551dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g403551g1002230918792.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ligand Announces Record Date and Details for Distribution for OmniAb
<FONT STYLE="white-space:nowrap">Spin-Off</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EMERYVILLE, Calif. (October 3, 2022) &#150; Ligand Pharmaceuticals Incorporated (NASDAQ:
LGND)</B> today announced that its board of directors has set October&nbsp;26, 2022 as the record date (Record Date) for the dividend of shares of common stock of OmniAb, Inc. to be distributed to Ligand shareholders in order to effect the
separation of Ligand and OmniAb into two independent, publicly traded companies. The dividend in OmniAb shares is expected to be distributed to Ligand shareholders on or about November&nbsp;1, 2022, the expected closing date of the previously
announced business combination (Business Combination) between OmniAb and Avista Public Acquisition Corp. II (APAC) (NASDAQ: AHPA). Following the closing of the Business Combination, APAC will change its name to &#147;OmniAb, Inc.&#148; (New OmniAb)
and begin trading on the Nasdaq Global Market under the stock ticker symbol &#147;OABI,&#148; and Ligand will continue to trade on the Nasdaq Global Market under the stock ticker symbol &#147;LGND.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand shareholders as of the close of business on the Record Date will receive shares of OmniAb common stock on a pro rata basis representing 100% of
Ligand&#146;s interest in OmniAb. Immediately following the distribution of OmniAb shares, the Business Combination is expected to close. Upon the closing of the Business Combination, all shares of OmniAb common stock will be automatically exchanged
for shares of New OmniAb on a pro rata basis according to a base exchange ratio (Base Exchange Ratio) calculated immediately prior to closing using a formula set forth in the merger agreement (Merger Agreement) among Ligand, OmniAb, APAC and a
subsidiary of APAC. The Base Exchange Ratio is based on the number of shares of Ligand common stock outstanding and the relative trading values of the Ligand common stock in the &#147;regular way&#148; and
<FONT STYLE="white-space:nowrap">&#147;ex-distribution&#148;</FONT> markets during the <FONT STYLE="white-space:nowrap">five-trading-day</FONT> period prior to the closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on an illustrative record date of June&nbsp;30, 2022 and Ligand stock price as of such date and an estimated Base Exchange Ratio, Ligand shareholders
would receive approximately 4.9 shares of New OmniAb common stock for each share of Ligand/OmniAb common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, as part of the exchange,
Ligand shareholders as of the Record Date will receive earnout shares (Earnout Shares) of New OmniAb common stock on a pro rata basis according to an earnout exchange ratio (Earnout Exchange Ratio) calculated immediately prior to closing using a
formula set forth in the Merger Agreement. Based on an illustrative record date of June&nbsp;30, 2022 and Ligand stock price as of such date and an estimated Earnout Exchange Ratio, Ligand shareholders would receive approximately 0.75 shares of New
OmniAb common stock for each share of Ligand/OmniAb common stock. The Earnout Shares will vest based upon the achievement of certain volume-weighted average trading prices for shares of New OmniAb during the five-year period following the closing of
the Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the foregoing estimates, Ligand&#146;s shareholders would receive aggregate shares of New OmniAb common stock
representing approximately 76.3% (assuming no redemptions by APAC shareholders) to 85.0% (assuming maximum redemptions by APAC shareholders) of New OmniAb, APAC&#146;s existing public shareholders would own approximately 18.0% (assuming no
redemptions by APAC shareholders) to 0% (assuming maximum redemptions by APAC shareholders) of New OmniAb, and the sponsor and related parties of APAC (Sponsor) would own approximately 5.7% (assuming no redemptions by APAC shareholders) to 15.0%
(assuming maximum redemptions by APAC shareholders) of New OmniAb, including the Earnout Shares in each case. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The actual number of shares of New OmniAb
common stock and Earnout Shares that each Ligand shareholder will receive with respect to each share of OmniAb common stock will be calculated on the closing date and may differ from these estimates. No fractional shares of New OmniAb common stock
will be issued in the merger, and instead Ligand shareholders will receive cash in lieu of any fractional share (other than with respect to Earnout Shares). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand shareholders do not need to take any action. Their OmniAb shares received upon distribution of the dividend will automatically be exchanged for New
OmniAb common stock and Earnout Shares in the merger on the closing date of the Business Combination. Following the closing of the Business Combination, Ligand shareholders will continue to hold, along with their new shares of New OmniAb common
stock and Earnout Shares, the same number of shares of Ligand common stock that they held immediately prior to the closing. After the closing, investors should expect that Ligand&#146;s share price will adjust to reflect the transfer of the OmniAb
business to New OmniAb. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination, OmniAb and APAC filed registration statements with the
Securities and Exchange Commission (SEC), described below under &#147;Important Information and Where to Find It.&#148; On September&nbsp;30, 2022, the SEC declared both registration statements effective. The registration statements contain further
information regarding the <FONT STYLE="white-space:nowrap">spin-off</FONT> and Business Combination, including the conditions to completion of the Business Combination and additional details regarding the calculation of the applicable exchange
ratios described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Factors that May Affect the Dividend and <FONT STYLE="white-space:nowrap">Spin-Off</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The dividend is conditioned upon, and the <FONT STYLE="white-space:nowrap">spin-off</FONT> and Business Combination are subject to, the satisfaction or waiver
of closing conditions for the Business Combination. If certain closing conditions are not satisfied or waived in advance of the expected closing date, Ligand may elect to change the record date for the dividend to a later date or to not proceed with
the dividend or the <FONT STYLE="white-space:nowrap">spin-off.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Two-Way</FONT> Trading to Begin for Ligand on
the Nasdaq Global Market (Nasdaq) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beginning on or around the trading day prior to the Record Date and continuing through the close of trading on the
closing date of the Business Combination, there will be two markets in Ligand common stock on Nasdaq: a &#147;regular way&#148; market and an <FONT STYLE="white-space:nowrap">&#147;ex-distribution&#148;</FONT> market. During this period of <FONT
STYLE="white-space:nowrap">two-way</FONT> trading in Ligand common stock, there will also be a market on Nasdaq for New OmniAb common stock on a &#147;when issued&#148; basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The trading options that will be available during the <FONT STYLE="white-space:nowrap">two-way</FONT> trading period are: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Ligand Regular Way Trading </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, during the period of <FONT
STYLE="white-space:nowrap">two-way</FONT> trading, a Ligand shareholder sells a share of Ligand common stock in the regular way market under Ligand&#146;s Nasdaq symbol, &#147;LGND,&#148; the shareholder will be selling both the share of Ligand
common stock and the right to receive shares of New OmniAb common stock in the transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Ligand Ex-distribution Trading </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, during the period of <FONT STYLE="white-space:nowrap">two-way</FONT> trading, a Ligand shareholder sells a share of Ligand common stock in the <FONT
STYLE="white-space:nowrap">ex-distribution</FONT> market under the temporary Nasdaq symbol &#147;LGNDV,&#148; the Ligand shareholder will be selling only a share of Ligand common stock and will retain the right to receive shares of New OmniAb common
stock in the transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>New OmniAb When issued Trading </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the <FONT STYLE="white-space:nowrap">two-way</FONT> trading period, a Ligand shareholder also has the option of selling the right to receive shares of
New OmniAb common stock while retaining shares of Ligand common stock. This option will be available under the temporary Nasdaq symbol &#147;OABIV.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trades under the symbols &#147;OABIV&#148; and &#147;LGNDV&#148; will settle after the closing date of the Business Combination. If the transaction is not
completed, all trades made under these temporary symbols will be cancelled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In all cases, investors should consult with their financial and tax advisors
regarding the specific implications of selling shares of their Ligand common stock or the right to receive shares of New OmniAb common stock on or before the closing date of the Business Combination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About OmniAb<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OmniAb&#146;s discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and high-throughput screening
technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> (BI) of our proprietary transgenic animals, including
OmniRat, OmniChicken and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address
industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur features unique structural attributes of cow antibodies for complex targets. We believe the OmniAb animals comprise the most diverse host systems
available in the industry and they are optimally leveraged through computational </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
antigen design and immunization methods, paired with high-throughput single B cell phenotypic screening and mining of next-generation sequencing datasets with custom algorithms to identify fully
human antibodies with superior performance and developability characteristics. An established core competency focused on ion channels and transporters further differentiates our technology and creates opportunities in emerging target classes. OmniAb
antibodies have been leveraged across modalities, including bispecific antibodies, antibody-drug conjugates and others. The OmniAb suite of technologies span from <FONT STYLE="white-space:nowrap">BI-powered</FONT> repertoire generation to cutting
edge antibody discovery and optimization offering a highly efficient and customizable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-to-end</FONT></FONT> solution for the growing discovery needs of the global pharmaceutical
industry. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Avista Public Acquisition Corp. II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">APAC is a special purpose acquisition company that completed its initial public offering in August 2021. APAC was formed for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase, reorganization or business combination with one or more businesses. APAC is sponsored by Avista Acquisition LP II, which was formed for the express purpose of acting as the sponsor for APAC.
Avista Acquisition Corp. is an affiliate of Avista Capital Holdings, L.P. For more information, please visit <U>www.avistapac.com/ahpac</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About
Ligand Pharmaceuticals </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help
pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low
corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing
what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization)
ultimately to generate our revenue. Ligand&#146;s OmniAb<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> technology platform is a patent-protected transgenic animal platform used in the discovery of fully human monoclonal and bispecific
therapeutic antibodies. The Captisol platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Ligand&#146;s Pelican Expression Technology is a robust,
validated, cost-effective and scalable platform for recombinant protein production that is especially well-suited for complex, large-scale protein production where traditional systems are not. Ligand has established multiple alliances, licenses and
other business relationships with the world&#146;s leading pharmaceutical companies including Amgen, Merck, Pfizer, Sanofi, Takeda, Gilead Sciences and Baxter International. For more information, please visit <U>www.ligand.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Follow Ligand on Twitter @Ligand_LGND. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important
Information and Where to Find It </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination, OmniAb filed with the SEC a registration statement on Form 10 (Form 10)
(File <FONT STYLE="white-space:nowrap">No.&nbsp;000-56427)</FONT> registering shares of OmniAb Common Stock and APAC filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (Form
<FONT STYLE="white-space:nowrap">S-4)</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-264525)</FONT> registering shares of New OmniAb Common Stock, warrants and certain equity awards. APAC has also filed a definitive proxy
statement/prospectus in connection with the APAC shareholder vote required in connection with the Business Combination. The Form 10 filed by OmniAb included portions of the Form <FONT STYLE="white-space:nowrap">S-4</FONT> filed by APAC, which will
serve as an information statement/prospectus in connection with the <FONT STYLE="white-space:nowrap">spin-off</FONT> of OmniAb. This communication does not contain all the information that should be considered concerning the Business Combination.
This communication is not a substitute for the registration statements that OmniAb and APAC filed or will file with the SEC or any other documents that APAC or OmniAb may file with the SEC, or that APAC, Ligand or OmniAb may send to stockholders in
connection with the Business Combination. It is not intended to form the basis of any investment decision or any other decision in respect to the Business Combination. APAC&#146;s shareholders, Ligand&#146;s stockholders and other interested persons
are advised to read the definitive registration statements, and documents incorporated by reference therein, as these materials will contain important information about APAC, OmniAb and the Business Combination. The definitive proxy
statement/prospectus will be mailed to APAC&#146;s shareholders as of the record date of September&nbsp;1, 2022 for voting on the Business Combination. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The registration statements, proxy statement/prospectus/information statement and other documents are also
available free of charge at the SEC&#146;s website at www.sec.gov or by directing a request to: Avista Public Acquisition Corp. II, 65 East 55th Street, 18th Floor, New York, NY 10022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in the Solicitation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand, APAC and
OmniAb, and each of their respective directors, executive officers and other members of their management and employees may be deemed to be participants in the solicitation of proxies from APAC&#146;s shareholders in connection with the Business
Combination. Shareholders are urged to carefully read the final proxy statement/prospectus/information statement because it contains important information. Information regarding the persons who may, under the rules of the SEC, be deemed participants
in the solicitation of APAC&#146;s shareholders in connection with the Business Combination is set forth in the registration statements filed with the SEC. Information about APAC&#146;s executive officers and directors and OmniAb&#146;s management
and directors also is set forth in the registration statements relating to the Business Combination. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Solicitation or Offer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication shall neither constitute an offer to sell nor the solicitation of an offer to buy any securities, or the solicitation of any proxy, vote,
consent or approval in any jurisdiction in connection with the Business Combination, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to any registration or qualification
under the securities laws of any such jurisdictions. This communication is restricted by law; it is not intended for distribution to, or use by any person in, any jurisdiction where such distribution or use would be contrary to local law or
regulation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This news
release contains forward-looking statements by Ligand that involve risks and uncertainties and reflect Ligand&#146;s judgment as of the date of this release. Words such as &#147;plans,&#148; &#147;believes,&#148; &#147;expects,&#148;
&#147;anticipates,&#148; and &#147;will,&#148; and similar expressions, are intended to identify forward-looking statements. These forward-looking statements include: the expected timing of the <FONT STYLE="white-space:nowrap">spin-off</FONT> of
OmniAb and Business Combination with APAC; the estimated Base Exchange Ratio and Earnout Exchange Ratio and aggregate ownership of New OmniAb by Ligand&#146;s and APAC&#146;s respective shareholders and by the Sponsor; the anticipated <FONT
STYLE="white-space:nowrap">two-way</FONT> trading market in Ligand common stock on Nasdaq and when-issued trading in New OmniAb common stock; and the ability of the parties to complete the proposed transaction. Actual events or results may differ
from Ligand&#146;s expectations due to risks and uncertainties inherent in Ligand&#146;s business, including, without limitation: the Business Combination may not be completed in accordance with the expected plans or anticipated timeline or at all;
and other risks described in Ligand&#146;s prior press releases and filings with the Securities and Exchange Commission available at www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the &#147;Risk Factors&#148; section of APAC&#146;s registration statement on Form <FONT
STYLE="white-space:nowrap">S-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-257177),</FONT> the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-264525),</FONT> the registration statement on Form 10 (File <FONT STYLE="white-space:nowrap">No.&nbsp;000-56427),</FONT> the proxy/information statement/prospectus and certain other documents filed or
that may be filed by APAC, Ligand or OmniAb from time to time with the SEC following the date hereof. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from
those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ligand, OmniAb and APAC assume no obligation
and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither Ligand, OmniAb, or APAC gives any assurance that Ligand, OmniAb or APAC will achieve their
expectations. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ligand Pharmaceuticals Incorporated</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">LHA Investor Relations</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Simon Latimer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bruce Voss</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>investors@ligand.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>bvoss@lhai.com</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(858) <FONT STYLE="white-space:nowrap">550-7766</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(310) <FONT STYLE="white-space:nowrap">691-7100</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Twitter: @Ligand_LGND</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">#&nbsp;&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;&nbsp;# </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lgnd-20221003.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 10/3/2022 3:14:16 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:lgnd="http://www.ligand.com/20221003"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.ligand.com/20221003"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20221003_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20221003_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lgnd-20221003_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 10/3/2022 3:14:16 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>lgnd-20221003_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 10/3/2022 3:14:16 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lgnd-20221003.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g403551g1002230918792.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g403551g1002230918792.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% ,0# 2(  A$! Q$!_\0
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MADRK2$@\>A->@^*K>YN+&(0H\D08^8BC=SM(4E?XE!Y(_P *\Y^'?_(X6_\
MUQD_E7LM 'G:Z5XG*@:-.UM;J2&!'E*[9/S*I&0,;1VY!^I*]$HH \"\/_\
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*BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140533594741728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  03,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3911 Sorrento Valley Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d403551d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lgnd-20221003.xsd" xlink:type="simple"/>
    <context id="duration_2022-10-03_to_2022-10-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-10-03</startDate>
            <endDate>2022-10-03</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2022-10-03_to_2022-10-03"
      id="Hidden_dei_EntityRegistrantName">LIGAND PHARMACEUTICALS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2022-10-03_to_2022-10-03">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-10-03_to_2022-10-03"
      id="Hidden_dei_EntityCentralIndexKey">0000886163</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-10-03_to_2022-10-03">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-10-03_to_2022-10-03">2022-10-03</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-10-03_to_2022-10-03">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-10-03_to_2022-10-03">001-33093</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-10-03_to_2022-10-03">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-10-03_to_2022-10-03">3911 Sorrento Valley Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-10-03_to_2022-10-03">Suite 110</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-10-03_to_2022-10-03">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-10-03_to_2022-10-03">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-10-03_to_2022-10-03">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-10-03_to_2022-10-03">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-10-03_to_2022-10-03">550-7500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-10-03_to_2022-10-03">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-10-03_to_2022-10-03">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-10-03_to_2022-10-03">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-10-03_to_2022-10-03">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-10-03_to_2022-10-03">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-10-03_to_2022-10-03">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-10-03_to_2022-10-03">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-10-03_to_2022-10-03">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7F!^*\'"6AQ<I6G'XU:UP,43]USQW#L<%EBQR8"]&&QI7]?K^O UZ#62537
MQ1/V_\BF:9H!62,@+ML(>++U;\C-W,^467W479&ET&'MZFL0,2/,=RO2_WY%
M$J;(CH49)S\[-U#T20(C3;=,H<15_G?QA+U4+# S;W&(5K)VWC4(/#_-)AA)
ME>Q=/#&7OGMX][<LWO"SYY(&H9FWF'A_8$Q5EG<ORO(/$5<;XZ4G4-!;,P<3
M%M<> AH$STXU^^1$;/Y=>&'FC2D)^1J$G)L>Z*KBP%XTM$SR0_)*:CARYY=;
MSF 9F [P?"VE_FB8<W?YM\GH'U!+ P04    " ! 2D-5GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( $!*0U4<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L)
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " ! 2D-5!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M $!*0U7-;BHQ[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( $!*0U697)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 0$I#58N:
MSLUW!   0A$  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( $!*0U6?H!OPL0(  .(,   -
M  "  ;L,  !X;"]S='EL97,N>&UL4$L! A0#%     @ 0$I#59>*NQS
M$P(   L              ( !EP\  %]R96QS+RYR96QS4$L! A0#%     @
M0$I#51PX9>H_ 0  / (   \              ( !@!   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( $!*0U4D'INBK0   /@!   :              "
M >P1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $!*
M0U5ED'F2&0$  ,\#   3              "  =$2  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  !L4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d403551d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d403551d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d403551d8k.htm">d403551d8k.htm</File>
    <File>d403551dex991.htm</File>
    <File>lgnd-20221003.xsd</File>
    <File>lgnd-20221003_lab.xml</File>
    <File>lgnd-20221003_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d403551d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d403551d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20221003_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20221003_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20221003.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20221003",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d403551d8k.htm",
      "contextRef": "duration_2022-10-03_to_2022-10-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d403551d8k.htm",
      "contextRef": "duration_2022-10-03_to_2022-10-03",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20221003/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-22-256260-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-256260-xbrl.zip
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M8*7&*0)E=SRW6VL=G;MV> RL.4:VN5<C=3LUIZK.&]NO!R]_%ZLRS\L8OTU
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M\6F)E7W]5&Y85=W(JZTT]K)R@9^,>P2JXKP<_LF>A34>A<Y';,:Q.#*7P/G
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MM"?@1K"1;9F'7$7@S\AFOK6UP.3)HF57]D/K88SA7RXA][P:LJU8DREM9C^
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M_7^7?W%']19LU/G1-WA(?SKI_P!02P,$%     @ 0$I#5:[P%\$^ P  30L
M !$   !L9VYD+3(P,C(Q,# S+GAS9+U6WV_3,!!^1^)_./($$HF;EB$M6H>
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MH=?M$?-F'N'4)7\!4$L! A0#%     @ 0$I#51Y7:%"/#P  ,V0   X
M         ( !     &0T,#,U-3%D.&LN:'1M4$L! A0#%     @ 0$I#5;V?
M@<G"&P  06D  !$              ( !NP\  &0T,#,U-3%D97@Y.3$N:'1M
M4$L! A0#%     @ 0$I#5:[P%\$^ P  30L  !$              ( !K"L
M &QG;F0M,C R,C$P,#,N>'-D4$L! A0#%     @ 0$I#5?O]#/U_!@  ND8
M !4              ( !&2\  &QG;F0M,C R,C$P,#-?;&%B+GAM;%!+ 0(4
M Q0    ( $!*0U5B>8.EQ 0  #PL   5              "  <LU  !L9VYD
G+3(P,C(Q,# S7W!R92YX;6Q02P4&      4 !0!  0  PCH

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
